The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Hydroxychloroquine Market Research Report 2025

Global Hydroxychloroquine Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1581798

No of Pages : 117

Ask Your Query

Synopsis

Hydroxychloroquine is a drug used to prevent and treat certain types of malaria. Specifically, it is used for chloroquine-sensitive malaria. Other uses include the treatment of rheumatoid arthritis, lupus and cutaneous porphyria. It is also used as an experimental treatment for coronavirus disease (COVID-19) in 2019.

Global Hydroxychloroquine market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Hydroxychloroquine market research.

Key manufacturers engaged in the Hydroxychloroquine industry include Sanofi, Novartis, Shanghai Zhongxisanwei, Teva, Zydus Cadila, Mylan, Apotex, Advanz Pharma and Sun Pharma, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % volume of Hydroxychloroquine were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Hydroxychloroquine market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Hydroxychloroquine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  •     Sanofi
  •     Novartis
  •     Shanghai Zhongxisanwei
  •     Teva
  •     Zydus Cadila
  •     Mylan
  •     Apotex
  •     Advanz Pharma
  •     Sun Pharma
  •     Kyung Poong
  •     Ipca Laboratories
  •     Hanlim Pharmaceutical
  •     Bristol Laboratories

Segment by Type

  •     100 mg
  •     200 mg
  •     Other

Segment by Application

  •     Lupus Erythematosus
  •     Rheumatoid Arthritis
  •     Others

Consumption by Region

  •  North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

The Hydroxychloroquine report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

 

  1.1 Product Overview and Scope of Hydroxychloroquine
    1.2 Hydroxychloroquine Segment by Type
        1.2.1 Global Hydroxychloroquine Market Value Comparison by Type (2023-2029)
        1.2.2 100 mg
        1.2.3 200 mg
        1.2.4 Other
    1.3 Hydroxychloroquine Segment by Application
        1.3.1 Global Hydroxychloroquine Market Value by Application: (2023-2029)
        1.3.2 Lupus Erythematosus
        1.3.3 Rheumatoid Arthritis
        1.3.4 Others
    1.4 Global Hydroxychloroquine Market Size Estimates and Forecasts
        1.4.1 Global Hydroxychloroquine Revenue 2018-2029
        1.4.2 Global Hydroxychloroquine Sales 2018-2029
        1.4.3 Global Hydroxychloroquine Market Average Price (2018-2029)
    1.5 Assumptions and Limitations

 2 Hydroxychloroquine Market Competition by Manufacturers
    2.1 Global Hydroxychloroquine Sales Market Share by Manufacturers (2018-2023)
    2.2 Global Hydroxychloroquine Revenue Market Share by Manufacturers (2018-2023)
    2.3 Global Hydroxychloroquine Average Price by Manufacturers (2018-2023)
    2.4 Global Hydroxychloroquine Industry Ranking 2021 VS 2022 VS 2023
    2.5 Global Key Manufacturers of Hydroxychloroquine, Manufacturing Sites & Headquarters
    2.6 Global Key Manufacturers of Hydroxychloroquine, Product Type & Application
    2.7 Hydroxychloroquine Market Competitive Situation and Trends
        2.7.1 Hydroxychloroquine Market Concentration Rate
        2.7.2 The Global Top 5 and Top 10 Largest Hydroxychloroquine Players Market Share by Revenue
        2.7.3 Global Hydroxychloroquine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

 3 Hydroxychloroquine Retrospective Market Scenario by Region
    3.1 Global Hydroxychloroquine Market Size by Region: 2018 Versus 2022 Versus 2029
    3.2 Global Hydroxychloroquine Global Hydroxychloroquine Sales by Region: 2018-2029
        3.2.1 Global Hydroxychloroquine Sales by Region: 2018-2023
        3.2.2 Global Hydroxychloroquine Sales by Region: 2024-2029
    3.3 Global Hydroxychloroquine Global Hydroxychloroquine Revenue by Region: 2018-2029
        3.3.1 Global Hydroxychloroquine Revenue by Region: 2018-2023
        3.3.2 Global Hydroxychloroquine Revenue by Region: 2024-2029
    3.4 North America Hydroxychloroquine Market Facts & Figures by Country
        3.4.1 North America Hydroxychloroquine Market Size by Country: 2018 VS 2022 VS 2029
        3.4.2 North America Hydroxychloroquine Sales by Country (2018-2029)
        3.4.3 North America Hydroxychloroquine Revenue by Country (2018-2029)
        3.4.4 U.S.
        3.4.5 Canada
    3.5 Europe Hydroxychloroquine Market Facts & Figures by Country
        3.5.1 Europe Hydroxychloroquine Market Size by Country: 2018 VS 2022 VS 2029
        3.5.2 Europe Hydroxychloroquine Sales by Country (2018-2029)
        3.5.3 Europe Hydroxychloroquine Revenue by Country (2018-2029)
        3.5.4 Germany
        3.5.5 France
        3.5.6 U.K.
        3.5.7 Italy
        3.5.8 Russia
    3.6 Asia Pacific Hydroxychloroquine Market Facts & Figures by Country
        3.6.1 Asia Pacific Hydroxychloroquine Market Size by Country: 2018 VS 2022 VS 2029
        3.6.2 Asia Pacific Hydroxychloroquine Sales by Country (2018-2029)
        3.6.3 Asia Pacific Hydroxychloroquine Revenue by Country (2018-2029)
        3.6.4 China
        3.6.5 Japan
        3.6.6 South Korea
        3.6.7 India
        3.6.8 Australia
        3.6.9 Taiwan
        3.6.10 Indonesia
        3.6.11 Thailand
        3.6.12 Malaysia
        3.6.13 Philippines
    3.7 Latin America Hydroxychloroquine Market Facts & Figures by Country
        3.7.1 Latin America Hydroxychloroquine Market Size by Country: 2018 VS 2022 VS 2029
        3.7.2 Latin America Hydroxychloroquine Sales by Country (2018-2029)
        3.7.3 Latin America Hydroxychloroquine Revenue by Country (2018-2029)
        3.7.4 Mexico
        3.7.5 Brazil
        3.7.6 Argentina
    3.8 Middle East and Africa Hydroxychloroquine Market Facts & Figures by Country
        3.8.1 Middle East and Africa Hydroxychloroquine Market Size by Country: 2018 VS 2022 VS 2029
        3.8.2 Middle East and Africa Hydroxychloroquine Sales by Country (2018-2029)
        3.8.3 Middle East and Africa Hydroxychloroquine Revenue by Country (2018-2029)
        3.8.4 Turkey
        3.8.5 Saudi Arabia
        3.8.6 UAE

 4 Segment by Type
    4.1 Global Hydroxychloroquine Sales by Type (2018-2029)
        4.1.1 Global Hydroxychloroquine Sales by Type (2018-2023)
        4.1.2 Global Hydroxychloroquine Sales by Type (2024-2029)
        4.1.3 Global Hydroxychloroquine Sales Market Share by Type (2018-2029)
    4.2 Global Hydroxychloroquine Revenue by Type (2018-2029)
        4.2.1 Global Hydroxychloroquine Revenue by Type (2018-2023)
        4.2.2 Global Hydroxychloroquine Revenue by Type (2024-2029)
        4.2.3 Global Hydroxychloroquine Revenue Market Share by Type (2018-2029)
    4.3 Global Hydroxychloroquine Price by Type (2018-2029)

 5 Segment by Application
    5.1 Global Hydroxychloroquine Sales by Application (2018-2029)
        5.1.1 Global Hydroxychloroquine Sales by Application (2018-2023)
        5.1.2 Global Hydroxychloroquine Sales by Application (2024-2029)
        5.1.3 Global Hydroxychloroquine Sales Market Share by Application (2018-2029)
    5.2 Global Hydroxychloroquine Revenue by Application (2018-2029)
        5.2.1 Global Hydroxychloroquine Revenue by Application (2018-2023)
        5.2.2 Global Hydroxychloroquine Revenue by Application (2024-2029)
        5.2.3 Global Hydroxychloroquine Revenue Market Share by Application (2018-2029)
    5.3 Global Hydroxychloroquine Price by Application (2018-2029)

 6 Key Companies Profiled
    6.1 Sanofi
        6.1.1 Sanofi Corporation Information
        6.1.2 Sanofi Description and Business Overview
        6.1.3 Sanofi Hydroxychloroquine Sales, Revenue and Gross Margin (2018-2023)
        6.1.4 Sanofi Hydroxychloroquine Product Portfolio
        6.1.5 Sanofi Recent Developments/Updates
    6.2 Novartis
        6.2.1 Novartis Corporation Information
        6.2.2 Novartis Description and Business Overview
        6.2.3 Novartis Hydroxychloroquine Sales, Revenue and Gross Margin (2018-2023)
        6.2.4 Novartis Hydroxychloroquine Product Portfolio
        6.2.5 Novartis Recent Developments/Updates
    6.3 Shanghai Zhongxisanwei
        6.3.1 Shanghai Zhongxisanwei Corporation Information
        6.3.2 Shanghai Zhongxisanwei Description and Business Overview
        6.3.3 Shanghai Zhongxisanwei Hydroxychloroquine Sales, Revenue and Gross Margin (2018-2023)
        6.3.4 Shanghai Zhongxisanwei Hydroxychloroquine Product Portfolio
        6.3.5 Shanghai Zhongxisanwei Recent Developments/Updates
    6.4 Teva
        6.4.1 Teva Corporation Information
        6.4.2 Teva Description and Business Overview
        6.4.3 Teva Hydroxychloroquine Sales, Revenue and Gross Margin (2018-2023)
        6.4.4 Teva Hydroxychloroquine Product Portfolio
        6.4.5 Teva Recent Developments/Updates
    6.5 Zydus Cadila
        6.5.1 Zydus Cadila Corporation Information
        6.5.2 Zydus Cadila Description and Business Overview
        6.5.3 Zydus Cadila Hydroxychloroquine Sales, Revenue and Gross Margin (2018-2023)
        6.5.4 Zydus Cadila Hydroxychloroquine Product Portfolio
        6.5.5 Zydus Cadila Recent Developments/Updates
    6.6 Mylan
        6.6.1 Mylan Corporation Information
        6.6.2 Mylan Description and Business Overview
        6.6.3 Mylan Hydroxychloroquine Sales, Revenue and Gross Margin (2018-2023)
        6.6.4 Mylan Hydroxychloroquine Product Portfolio
        6.6.5 Mylan Recent Developments/Updates
    6.7 Apotex
        6.6.1 Apotex Corporation Information
        6.6.2 Apotex Description and Business Overview
        6.6.3 Apotex Hydroxychloroquine Sales, Revenue and Gross Margin (2018-2023)
        6.4.4 Apotex Hydroxychloroquine Product Portfolio
        6.7.5 Apotex Recent Developments/Updates
    6.8 Advanz Pharma
        6.8.1 Advanz Pharma Corporation Information
        6.8.2 Advanz Pharma Description and Business Overview
        6.8.3 Advanz Pharma Hydroxychloroquine Sales, Revenue and Gross Margin (2018-2023)
        6.8.4 Advanz Pharma Hydroxychloroquine Product Portfolio
        6.8.5 Advanz Pharma Recent Developments/Updates
    6.9 Sun Pharma
        6.9.1 Sun Pharma Corporation Information
        6.9.2 Sun Pharma Description and Business Overview
        6.9.3 Sun Pharma Hydroxychloroquine Sales, Revenue and Gross Margin (2018-2023)
        6.9.4 Sun Pharma Hydroxychloroquine Product Portfolio
        6.9.5 Sun Pharma Recent Developments/Updates
    6.10 Kyung Poong
        6.10.1 Kyung Poong Corporation Information
        6.10.2 Kyung Poong Description and Business Overview
        6.10.3 Kyung Poong Hydroxychloroquine Sales, Revenue and Gross Margin (2018-2023)
        6.10.4 Kyung Poong Hydroxychloroquine Product Portfolio
        6.10.5 Kyung Poong Recent Developments/Updates
    6.11 Ipca Laboratories
        6.11.1 Ipca Laboratories Corporation Information
        6.11.2 Ipca Laboratories Hydroxychloroquine Description and Business Overview
        6.11.3 Ipca Laboratories Hydroxychloroquine Sales, Revenue and Gross Margin (2018-2023)
        6.11.4 Ipca Laboratories Hydroxychloroquine Product Portfolio
        6.11.5 Ipca Laboratories Recent Developments/Updates
    6.12 Hanlim Pharmaceutical
        6.12.1 Hanlim Pharmaceutical Corporation Information
        6.12.2 Hanlim Pharmaceutical Hydroxychloroquine Description and Business Overview
        6.12.3 Hanlim Pharmaceutical Hydroxychloroquine Sales, Revenue and Gross Margin (2018-2023)
        6.12.4 Hanlim Pharmaceutical Hydroxychloroquine Product Portfolio
        6.12.5 Hanlim Pharmaceutical Recent Developments/Updates
    6.13 Bristol Laboratories
        6.13.1 Bristol Laboratories Corporation Information
        6.13.2 Bristol Laboratories Hydroxychloroquine Description and Business Overview
        6.13.3 Bristol Laboratories Hydroxychloroquine Sales, Revenue and Gross Margin (2018-2023)
        6.13.4 Bristol Laboratories Hydroxychloroquine Product Portfolio
        6.13.5 Bristol Laboratories Recent Developments/Updates

 7 Industry Chain and Sales Channels Analysis
    7.1 Hydroxychloroquine Industry Chain Analysis
    7.2 Hydroxychloroquine Key Raw Materials
        7.2.1 Key Raw Materials
        7.2.2 Raw Materials Key Suppliers
    7.3 Hydroxychloroquine Production Mode & Process
    7.4 Hydroxychloroquine Sales and Marketing
        7.4.1 Hydroxychloroquine Sales Channels
        7.4.2 Hydroxychloroquine Distributors
    7.5 Hydroxychloroquine Customers

 8 Hydroxychloroquine Market Dynamics
    8.1 Hydroxychloroquine Industry Trends
    8.2 Hydroxychloroquine Market Drivers
    8.3 Hydroxychloroquine Market Challenges
    8.4 Hydroxychloroquine Market Restraints

 9 Research Finding and Conclusion

 10 Methodology and Data Source
    10.1 Methodology/Research Approach
        10.1.1 Research Programs/Design
        10.1.2 Market Size Estimation
        10.1.3 Market Breakdown and Data Triangulation
    10.2 Data Source
        10.2.1 Secondary Sources
        10.2.2 Primary Sources
    10.3 Author List
    10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock